Editorial Comment: A 16-yr follow-up of the european randomized study of screening for prostate cancer

Hugosson, J; Roobol, MJ; Månsson, M; Tammela, TLJ; Zappa, M; Nelen, V; Lott, Felipe

Hugosson, J; Roobol, MJ; Månsson, M; Tammela, TLJ; Zappa, M; Nelen, V; Lott, Felipe.

Hugosson, J; University of Göteborg. Institute of Clinical Sciences. Department of Urology. Göteborg. SE
Roobol, MJ; Erasmus Medical Centre. Rotterdam. NL
Månsson, M; University of Göteborg. Institute of Clinical Sciences. Department of Urology. Göteborg. SE
Tammela, TLJ; University of Tampere. Faculty of Medicine and Life Sciences. Tampere. FI
Zappa, M; ISPRO. Oncological network, Prevention, and Research Institute. Florence. IT
Nelen, V; Provinciaal Instituut voor Hygiëne. Antwerp. BE
Lott, Felipe; Instituto Nacional do Câncer - INCA. Rio de Janeiro. BR

Int. braz. j. urol ; 46(3): 465-466, May-June 2020.

Article in English | LILACS | ID: biblio-1090611

Subject(s)

Humans; Male; Prostatic Neoplasms; Early Detection of Cancer; Mass Screening; Follow-Up Studies; Prostate-Specific Antigen

Fulltext

XML

Search on Google

Full text: Available Index: LILACS (Americas) Main subject: Prostatic Neoplasms / Early Detection of Cancer Type of study: Controlled clinical trial / Diagnostic study / Observational study / Prognostic study / Screening study Limits: Humans / Male Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2020 Type: Article Affiliation country: Belgium / Brazil / Finland / Italy / Netherlands / Sweden Institution/Affiliation country: Erasmus Medical Centre/NL / ISPRO/IT / Instituto Nacional do Câncer - INCA/BR / Provinciaal Instituut voor Hygiëne/BE / University of Göteborg/SE / University of Tampere/FI

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

Search on Google